Researchers are studying possible GLP-1 benefits for kidney disease, liver disease, sleep apnea, inflammation, brain health and addiction-related cravings
A pharmacokinetic study in rats found that oral administration produced substantial plasma concentrations, with a maximum concentration of 2252 ng/mL and an elimination half-life of approximately 6.9 hours
Without widespread coverage: Higher income patients will get access through either insurance coverage or cash pay Fewer lower income patients will get access through programs like Ro which can go to battle for them against insurance companies and take on that burden that a concierge practice might Note: while Ro still increases access, and we see lower income patients sign up every day, I hope it goes without saying that we wont solve this problem alone
Each has distinct advantages and drawbacks that extend beyond simple pharmacokinetics
see its separate dosing guide for research-context framing
Yes, but maintain the cold chain